|
Volumn 10, Issue 10, 2002, Pages 3129-3134
|
Biological effects of G1 phase arrest compound, sesquicillin, in human breast cancer cell lines
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIMITOTIC AGENT;
ANTINEOPLASTIC AGENT;
CYCLIN A;
CYCLIN D1;
CYCLIN DEPENDENT KINASE INHIBITOR;
CYCLIN E;
PROTEIN P21;
SESQUICILLIN;
UNCLASSIFIED DRUG;
CDKN1A PROTEIN, HUMAN;
CYCLIN DEPENDENT KINASE INHIBITOR 1A;
CYCLINE;
NAPHTHALENE DERIVATIVE;
PROTEIN P53;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
BREAST CANCER;
CELL CULTURE;
CELL CYCLE G1 PHASE;
CONTROLLED STUDY;
DRUG IDENTIFICATION;
DRUG ISOLATION;
FUNGUS;
HUMAN;
HUMAN CELL;
IN VITRO STUDY;
TUMOR CELL LINE;
BREAST TUMOR;
CHEMISTRY;
DRUG EFFECT;
FEMALE;
ISOLATION AND PURIFICATION;
METABOLISM;
PATHOLOGY;
PHOSPHORYLATION;
MINK CELL FOCUS-FORMING VIRUS;
BREAST NEOPLASMS;
CYCLIN-DEPENDENT KINASE INHIBITOR P21;
CYCLINS;
FEMALE;
FUNGI;
G1 PHASE;
HUMANS;
NAPHTHALENES;
PHOSPHORYLATION;
TUMOR CELLS, CULTURED;
TUMOR SUPPRESSOR PROTEIN P53;
|
EID: 0036335794
PISSN: 09680896
EISSN: None
Source Type: Journal
DOI: 10.1016/S0968-0896(02)00225-0 Document Type: Article |
Times cited : (14)
|
References (21)
|